TuHURA BIOSCIENCES, INC./NV Amortization of Intangible Assets
TuHURA BIOSCIENCES, INC./NV (HURA) reported Amortization of Intangible Assets of $3.23 million for the 12-month period ending 2023-06-30, per its 10-K filed 2023-09-18.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2023-09-18
- TuHURA BIOSCIENCES, INC./NV amortization of intangible assets for the quarter ending 2021-06-30 was $0.00, a 100.00% decline year-over-year.
- TuHURA BIOSCIENCES, INC./NV amortization of intangible assets for the quarter ending 2021-03-31 was $0.00, a 100.00% decline year-over-year.
- TuHURA BIOSCIENCES, INC./NV amortization of intangible assets for the quarter ending 2020-12-31 was $1.00K, a 66.67% decline year-over-year.
- TuHURA BIOSCIENCES, INC./NV amortization of intangible assets for the quarter ending 2020-09-30 was $1.00K, a 66.67% decline year-over-year.
- TuHURA BIOSCIENCES, INC./NV amortization of intangible assets for fiscal 2023 was $3.23M.
- TuHURA BIOSCIENCES, INC./NV amortization of intangible assets for fiscal 2021 was $2.00K, a 80.00% decline from fiscal 2020.
- TuHURA BIOSCIENCES, INC./NV amortization of intangible assets for fiscal 2020 was $10.00K, a 38.83% decline from fiscal 2019.
- TuHURA BIOSCIENCES, INC./NV amortization of intangible assets for fiscal 2019 was $16.35K, a 33.35% decline from fiscal 2018.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 3 month as first filed | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 6 month as first filed | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 9 month as first filed | Amortization of Intangible Assets 12 month | Amortization of Intangible Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2023-06-30 | $3.23M 10-K · filed 2023-09-18 | |||||||
| 2021-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-27 | $0.00 derived: sum of 2 quarters · filed 2022-09-27 | $1.00K derived: sum of 3 quarters · filed 2022-09-27 | $2.00K 10-K · filed 2022-09-27 | ||||
| 2021-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-05-13 | $1.00K derived: sum of 2 quarters · filed 2022-05-13 | $2.00K 10-Q · filed 2022-05-13 | $4.00K derived: sum of 4 quarters · filed 2022-05-13 | ||||
| 2020-12-31 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-02-11 | $2.00K 10-Q · filed 2022-02-11 | $4.00K derived: sum of 3 quarters · filed 2022-02-11 | $6.00K derived: sum of 4 quarters · filed 2022-02-11 | ||||
| 2020-09-30 | $1.00K 10-Q · filed 2021-11-15 | $3.00K derived: sum of 2 quarters · filed 2021-11-15 | $5.00K derived: sum of 3 quarters · filed 2021-11-15 | $8.00K derived: sum of 4 quarters · filed 2021-11-15 | ||||
| 2020-06-30 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-28 | $4.00K derived: sum of 2 quarters · filed 2021-09-28 | $7.00K derived: sum of 3 quarters · filed 2021-09-28 | $10.00K 10-K · filed 2021-09-28 | $9.95K 10-K · filed 2020-09-18 | |||
| 2020-03-31 | $2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-13 | $5.00K derived: sum of 2 quarters · filed 2021-05-13 | $8.00K 10-Q · filed 2021-05-13 | $8.40K 10-Q · filed 2020-05-13 | $10.80K derived: sum of 4 quarters · filed 2021-05-13 | |||
| 2019-12-31 | $3.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-02-12 | $6.00K 10-Q · filed 2021-02-12 | $5.60K 10-Q · filed 2020-02-13 | $8.80K derived: sum of 3 quarters · filed 2021-02-12 | $11.60K derived: sum of 4 quarters · filed 2021-02-12 | |||
| 2019-09-30 | $3.00K 10-Q · filed 2020-11-12 | $2.80K 10-Q · filed 2019-11-13 | $5.80K derived: sum of 2 quarters · filed 2020-11-12 | $8.60K derived: sum of 3 quarters · filed 2020-11-12 | $12.69K derived: sum of 4 quarters · filed 2020-11-12 | |||
| 2019-06-30 | $2.80K derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-18 | $5.60K derived: sum of 2 quarters · filed 2020-09-18 | $9.69K derived: sum of 3 quarters · filed 2020-09-18 | $16.35K 10-K · filed 2020-09-18 | ||||
| 2019-03-31 | $2.80K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-13 | $6.89K derived: sum of 2 quarters · filed 2020-05-13 | $13.55K 10-Q · filed 2020-05-13 | $20.21K derived: sum of 4 quarters · filed 2020-05-13 | ||||
| 2018-12-31 | $4.09K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-02-13 | $10.75K 10-Q · filed 2020-02-13 | $17.41K derived: sum of 3 quarters · filed 2020-02-13 | $24.06K derived: sum of 4 quarters · filed 2020-02-13 | ||||
| 2018-09-30 | $6.66K 10-Q · filed 2019-11-13 | $13.32K derived: sum of 2 quarters · filed 2019-11-13 | $19.98K derived: sum of 3 quarters · filed 2019-11-13 | $25.58K derived: sum of 4 quarters · filed 2019-11-13 | ||||
| 2018-06-30 | $6.66K derived: 10-K 12 month − 10-Q 9 month · filed 2019-09-09 | $13.32K derived: sum of 2 quarters · filed 2019-09-09 | $18.92K derived: sum of 3 quarters · filed 2019-09-09 | $24.53K 10-K · filed 2019-09-09 | ||||
| 2018-03-31 | $6.66K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-14 | $12.26K derived: sum of 2 quarters · filed 2019-05-14 | $17.87K 10-Q · filed 2019-05-14 | $22.98K derived: sum of 4 quarters · filed 2019-06-03 | ||||
| 2017-12-31 | $5.61K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-02-11 | $11.21K 10-Q · filed 2019-02-11 | $16.32K derived: sum of 3 quarters · filed 2019-06-03 | $20.18K derived: sum of 4 quarters · filed 2019-06-03 | ||||
| 2017-09-30 | $5.61K 10-Q · filed 2018-11-13 | $10.71K derived: sum of 2 quarters · filed 2019-06-03 | $14.57K derived: sum of 3 quarters · filed 2019-06-03 | $18.43K derived: sum of 4 quarters · filed 2019-06-03 | ||||
| 2017-06-30 | $5.11K derived: 8-K 12 month − 10-Q 9 month · filed 2019-06-03 | $8.97K derived: sum of 2 quarters · filed 2019-06-03 | $12.82K derived: sum of 3 quarters · filed 2019-06-03 | $16.68K 8-K · filed 2019-06-03 | ||||
| 2017-03-31 | $3.86K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-15 | $7.72K derived: sum of 2 quarters · filed 2018-05-15 | $11.57K 10-Q · filed 2018-05-15 | |||||
| 2016-12-31 | $3.86K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-14 | $7.72K 10-Q · filed 2018-02-14 | ||||||
| 2016-09-30 | $3.86K 10-Q · filed 2017-11-09 | |||||||
| 2016-06-30 | $10.29K 10-K · filed 2017-09-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |